go-v.orgdoi

Imaging Biomarkers in Systemic Disease: Quantitative Radiology and Precision Medicine in Clinical Practice

Richard Adrián Vergara Trujillo, Joseph Rodríguez Sánchez, Milton Fernando Crespo Macias, Borely Josué Uribio Alemán, Juan Pablo Monroy Moreno, Jorge Angel Velasco Espinal, Alexa Fernanda Uriostegui Navarro, Alma Valeria Popoca García · International Science Journal · 2026

  • DOI 10.64784/220
  • Publisher OpenAlex
  • Type article
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

International Science Journal · OpenAlex · article · 2026

Abstract

Imaging biomarkers have progressively transformed modern radiology by providing quantitative, functional, and molecular information capable of improving early disease detection, diagnostic precision, therapeutic monitoring, and clinical decision-making in systemic diseases. The present review aimed to analyze the current role of imaging biomarkers in oncology and internal medicine, emphasizing their contribution to precision medicine and multidisciplinary healthcare management. A structured documentary review was conducted using peer-reviewed scientific literature indexed in internationally recognized databases, including PubMed, Scopus, ScienceDirect, and SpringerLink.

The analyzed evidence focused on advanced imaging modalities such as computed tomography, magnetic resonance imaging, positron emission tomography, hybrid imaging systems, radiomics, and artificial intelligence-assisted imaging analysis. The reviewed studies demonstrated that imaging biomarkers possess broad applicability in oncology, neurological disorders, cardiovascular diseases, inflammatory conditions, chronic hepatic disease, pulmonary pathology, and metabolic disorders. Functional and molecular imaging techniques showed particular relevance for evaluating metabolism, tissue perfusion, angiogenesis, fibrosis, inflammation, cellular density, and tumor heterogeneity.

Radiomics and artificial intelligence were identified as emerging technologies capable of improving predictive analysis, treatment response assessment, and individualized therapeutic planning.

Open the resolved locator · 10.64784/220

Metadata licence: OpenAlex metadata (CC0)